Posttraumatic bleeding reduction by systemic administration of fibrin monomer in thrombolytic therapy

Posttraumatic bleeding reduction by systemic administration of fibrin monomer in thrombolytic therapy

<p><strong>Background.</strong> There is a continued search for effective and safe drugs with systemic hemostatic effects. Experimental data from previous studies show that low-dose fibrin monomer (FM) can reduce posttraumatic bleeding without causing activation of clotting in the...

Full description

Bibliographic Details
Main Authors: V. M. Vdovin, A. P. Momot, D. A. Orekhov, V. O. Krasyukova, I. I. Shakhmatov, N. A. Lycheva, D. A. Momot, V. E. Chernus, V. V. Terjaev
Format: Article
Language:Russian
Published: Meshalkin National Medical Research Center 2020-04-01
Series:Патология кровообращения и кардиохирургия
Subjects:
гемостатический эффект
посттравматическая кровопотеря
стрептокиназа
транексамовая кислота
фибрин-мономер
Online Access:http://journalmeshalkin.ru/index.php/heartjournal/article/view/804

Internet

http://journalmeshalkin.ru/index.php/heartjournal/article/view/804

Similar Items